Document is current
Any future updates will be listed below
-
Authors
Agarwal, Puja https://orcid.org/0000-0002-0274-6653
Ayton, Scott https://orcid.org/0000-0002-3479-2427
Agrawal, Sonal https://orcid.org/0000-0003-2375-8888
Dhana, Klodian
Bennett, David A.
Barnes, Lisa L.
Leurgans, Sue E. https://orcid.org/0000-0003-2536-1665
Bush, Ashley I. https://orcid.org/0000-0001-8259-9069
Schneider, Julie A. https://orcid.org/0000-0002-9482-1752
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG054057, R01AG017917)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Department of Health | National Health and Medical Research Council (..)
National Institute of Health
- License Information
-
More Information
Article History
Received: 7 December 2021
Revised: 25 August 2022
Accepted: 14 September 2022
First Online: 4 October 2022
Competing interests
: AIB Holds equity: Alterity Biotechnology Ltd, Cogstate Ltd, Mesoblast Ltd, Collaborative Medicinal Development LLC. Paid consultant: Collaborative Medicinal Development Pty Ltd. Julie A Schneider and other authors report no competing interests.
